ZA200500877B - Antimicrobial aza-bicyclic derivatives, their compositions and uses. - Google Patents

Antimicrobial aza-bicyclic derivatives, their compositions and uses.

Info

Publication number
ZA200500877B
ZA200500877B ZA200500877A ZA200500877A ZA200500877B ZA 200500877 B ZA200500877 B ZA 200500877B ZA 200500877 A ZA200500877 A ZA 200500877A ZA 200500877 A ZA200500877 A ZA 200500877A ZA 200500877 B ZA200500877 B ZA 200500877B
Authority
ZA
South Africa
Prior art keywords
aza
antimicrobial
compositions
bicyclic derivatives
bicyclic
Prior art date
Application number
ZA200500877A
Other languages
English (en)
Inventor
Benoit Ledoussal
Xiufeng Eric Hu
Ji-In Almstead
Jeffrey Lyle Gray
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of ZA200500877B publication Critical patent/ZA200500877B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA200500877A 2002-07-31 2005-01-31 Antimicrobial aza-bicyclic derivatives, their compositions and uses. ZA200500877B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40001402P 2002-07-31 2002-07-31

Publications (1)

Publication Number Publication Date
ZA200500877B true ZA200500877B (en) 2006-02-20

Family

ID=31715691

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200500877A ZA200500877B (en) 2002-07-31 2005-01-31 Antimicrobial aza-bicyclic derivatives, their compositions and uses.

Country Status (17)

Country Link
US (1) US6900224B2 (xx)
EP (1) EP1532137A2 (xx)
JP (1) JP2005536532A (xx)
KR (1) KR20050026074A (xx)
CN (1) CN1671690A (xx)
AU (1) AU2003259169A1 (xx)
BR (1) BR0313420A (xx)
CA (1) CA2493146A1 (xx)
IL (1) IL166041A0 (xx)
MA (1) MA27467A1 (xx)
MX (1) MXPA05001180A (xx)
NO (1) NO20051082L (xx)
NZ (1) NZ537203A (xx)
PL (1) PL375388A1 (xx)
RU (1) RU2005105337A (xx)
WO (1) WO2004014893A2 (xx)
ZA (1) ZA200500877B (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK286420B6 (sk) * 1997-09-15 2008-09-05 The Procter & Gamble Company Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie
NZ519783A (en) * 1999-12-28 2005-05-27 Teikoku Seiyaku Co Antipruritic agents for external use
US7354916B2 (en) * 2003-04-07 2008-04-08 Cylene Pharmaceuticals Substituted quinobenzoxazine analogs
KR100944600B1 (ko) * 2003-04-07 2010-02-25 사일린 파마슈티칼스, 인크 치환된 퀴노벤족사진 유사체
US7507727B2 (en) * 2003-04-07 2009-03-24 Cylene Pharmaceuticals, Inc. Substituted quinobenzoxazine analogs and methods of using thereof
WO2004091627A2 (en) * 2003-04-07 2004-10-28 Cylene Pharmaceuticals, Inc. Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs
KR100989029B1 (ko) * 2004-09-17 2010-10-25 사일린 파마슈티칼스, 인크 세포 증식 억제제로서의 퀴놀론 동족체
US7652134B2 (en) * 2004-09-17 2010-01-26 Cylene Pharmaceuticals, Inc. Methods for converting quinolone esters into quinolone amides
BRPI0709772B8 (pt) * 2006-03-28 2021-05-25 The Protecter & Gamble Company sais de malato e polimorfos do ácido (3s,5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-diidro-8-metóxi-4-oxo-3-quinolinocarboxílico
CA2647454A1 (en) * 2006-03-28 2007-10-04 The Procter & Gamble Company A coupling process for preparing quinolone intermediates
US7528264B2 (en) 2006-03-28 2009-05-05 The Procter & Gamble Company Hydride reduction process for preparing quinolone intermediates
US7723355B2 (en) * 2006-11-20 2010-05-25 Bristol-Myers Squibb Company 7,8-dihydro-1,6-naphthyridin-5(6H)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods
US8658183B2 (en) * 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
KR101601332B1 (ko) 2007-10-05 2016-03-08 센화 바이오사이언시즈 인코포레이티드 퀴놀론 유사체 및 이와 관련된 방법
US8211909B2 (en) * 2008-07-01 2012-07-03 Taigen Biotechnology Co., Ltd. Treatment of antibiotic-resistant bacteria infection
CN101618039B (zh) * 2008-07-02 2012-04-11 太景生物科技股份有限公司 肺炎的治疗药物
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2937034B1 (fr) * 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
FR2936951B1 (fr) * 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
TWI386395B (zh) * 2008-12-15 2013-02-21 Taigen Biotechnology Co Ltd 哌啶衍生物的立體有擇合成
CN102093260B (zh) * 2009-12-14 2014-03-05 太景生物科技股份有限公司 哌啶衍生物的立体有择合成
AU2016355268B2 (en) 2015-11-20 2021-08-19 Senhwa Biosciences, Inc. Combination therapy of tetracyclic quinolone analogs for treating cancer
US9957282B2 (en) 2015-12-14 2018-05-01 Senhwa Biosciences, Inc. Crystalline forms of quinolone analogs and their salts
US10329289B2 (en) 2015-12-23 2019-06-25 Merck Sharp & Dohme Corp. 6,7-dihydro-5H-pyrrolo[3,4-B]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor
WO2017107089A1 (en) 2015-12-23 2017-06-29 Merck Sharp & Dohme Corp. 3- (1h-pyrazol-4-yl) pyridineallosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018112840A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6, 5-fused heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018112843A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018112842A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6,6-fused heteroaryl piperidine ether allosteric modulators of m4 muscarinic acetylcholine receptor
WO2019000238A1 (en) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. 5- (PYRIDIN-3-YL) OXAZOLE ALLOSTERIC MODULATORS OF M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
WO2019000236A1 (en) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. ALLOSTERIC MODULATORS OF 3- (1H-PYRAZOL-4-YL) PYRIDINE FROM THE M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
WO2019000237A1 (en) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. ALLOSTERIC MODULATORS OF 3- (1H-PYRAZOL-4-YL) PYRIDINE FROM THE M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
JP7445597B2 (ja) 2018-02-15 2024-03-07 センワ バイオサイエンシズ インコーポレイテッド キノロン類似体及びそれらの塩、組成物、ならびにそれらの使用方法
EP3784656B1 (de) * 2018-04-25 2023-06-28 Elanco Animal Health GmbH Verfahren zur hydrolyse von chinoloncarbonsäureestern

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340285C (en) 1988-05-19 1998-12-22 Hiroyuki Nagano Novel quinolonecarboxylic acid derivatives having at 7-position a piperidin-1-yl substituent
JPH09503783A (ja) * 1993-10-14 1997-04-15 アボツト・ラボラトリーズ キノリジノン型化合物
JPH11510478A (ja) * 1995-06-06 1999-09-14 アボツト・ラボラトリーズ キノリジノン型化合物
KR100241673B1 (ko) * 1997-08-09 2000-03-02 김충섭 퀴놀리진 카르복실산 유도체
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
SK286420B6 (sk) * 1997-09-15 2008-09-05 The Procter & Gamble Company Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9914486D0 (en) 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
MXPA02005989A (es) * 2000-01-24 2002-10-23 Warner Lambert Co Agentes antibacteriales de 3-aminoquinazolin-2,4-diona.
JP2004515548A (ja) 2000-12-14 2004-05-27 ザ プロクター アンド ギャンブル カンパニー 抗微生物キノロン

Also Published As

Publication number Publication date
WO2004014893A2 (en) 2004-02-19
NO20051082L (no) 2005-04-29
US20040038975A1 (en) 2004-02-26
PL375388A1 (en) 2005-11-28
AU2003259169A1 (en) 2004-02-25
JP2005536532A (ja) 2005-12-02
MA27467A1 (fr) 2005-08-01
MXPA05001180A (es) 2005-05-16
BR0313420A (pt) 2005-06-28
WO2004014893A3 (en) 2004-04-08
CN1671690A (zh) 2005-09-21
US6900224B2 (en) 2005-05-31
IL166041A0 (en) 2006-01-15
EP1532137A2 (en) 2005-05-25
CA2493146A1 (en) 2004-02-19
RU2005105337A (ru) 2006-01-20
NZ537203A (en) 2007-02-23
KR20050026074A (ko) 2005-03-14

Similar Documents

Publication Publication Date Title
ZA200500877B (en) Antimicrobial aza-bicyclic derivatives, their compositions and uses.
ZA200501431B (en) 5-Aryltetrazole compounds, compositions thereof, and uses therefor.
MXPA03008798A (es) Composiciones antibacterianas.
ZA200305993B (en) Herbicidal compositions.
AP2005003198A0 (en) Spiroindolinepiperidine derivatives.
ZA200500170B (en) Indole-3-sulphur derivatives.
EP1542699A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
HK1090368A1 (en) 2,3,6-trisubstituted-4-pyrimidone derivatives
HUP0600027A2 (en) Antiseptic compositions, methods and systems
ZA200304090B (en) Agricultural articles.
HK1084873A1 (en) Antimicrobial compositions
EP1617807A4 (en) SUBSTITUTED 1,4-DIAZEPINE AND ITS USES
MXPA03006241A (es) Composiciones desodorantes antimicrobianas.
EP1902724A3 (en) Antimicrobial compositions
AP2005003195A0 (en) Herbicidal compositions.
ZA200305185B (en) Anti-microbial composition.
ZA200302929B (en) Compositions comprising cyclohexamantane.
MXPA03007693A (es) Composicion para la piel.
ZA200501387B (en) Antimicrobial compositions.
MXPA03009002A (es) 5-halogeno-6-fenil-7-fluoroalquilamino-triazolopirimidinas.
EG23378A (en) Composition.
ZA200306923B (en) Fungicide compositions.
EG23207A (en) Novel fungicidal compositions based on propamocarsand pyridylmethylbenzamide derivatives.
GB0307695D0 (en) Compounds,compositions and processes
AU2003269177A1 (en) Antimicrobial compositions